| Vanessa Daisy Lee, MD | |
|
2920 N Cascade Ave, Ste 301, Colorado Springs, CO 80907-6265 | |
| (719) 636-1201 | |
| (719) 636-1326 |
| Full Name | Vanessa Daisy Lee |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 21 Years |
| Location | 2920 N Cascade Ave, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912111691 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 0101242309 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uch-memorial Health System | Colorado springs, CO | Hospital |
| Centura Health-penrose St Francis Health Services | Colorado springs, CO | Hospital |
| Uchealth Grandview Hospital | Colorado springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peak Gastroenterology Associates | 2961484365 | 25 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Trinidad Area Health Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467400309 PECOS PAC ID: 2769394055 Enrollment ID: O20031111000178 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Salida Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972778272 PECOS PAC ID: 3577451152 Enrollment ID: O20040413000292 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Peak Gastroenterology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023112117 PECOS PAC ID: 2961484365 Enrollment ID: O20040601000848 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Salida Hospital District |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1730258971 PECOS PAC ID: 3577451152 Enrollment ID: O20081209000720 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Brim Healthcare Of Colorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275703910 PECOS PAC ID: 2860584224 Enrollment ID: O20090506000397 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vanessa Daisy Lee, MD 2920 N Cascade Ave, Ste 301, Colorado Springs, CO 80907-6265 Ph: (719) 636-1201 | Vanessa Daisy Lee, MD 2920 N Cascade Ave, Ste 301, Colorado Springs, CO 80907-6265 Ph: (719) 636-1201 |
News Archive
College students who exercised vigorously for 20 minutes at least three days a week were less likely to report poor mental health and perceived stress, according to a study in the American Journal of Health Promotion. However, socializing-defined in the study as having five or more friends or spending more than 2 hours a day with others-mediates this finding somewhat, revealing that some of the benefits of physical activity may come from its social aspects.
Researchers have identified the main risk factors for renal functional abnormalities in children with high-grade vesicoureteral reflux.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.
ProteinSimple today introduced the FluorChem R system as the next member of the FluorChem product family. The FluorChem R system is a fully integrated, multimode gel and Western blot imager with chemiluminescent, fluorescent, and infrared detection capabilities.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
› Verified 8 days ago
Michael Judd Burkholz, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2940 N Circle Dr, Colorado Springs, CO 80909 Phone: 719-635-7321 Fax: 719-635-2510 | |
Mrs. Rachel Elizabeth Black, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 2222 N Nevada Ave Ste 4004, Colorado Springs, CO 80907 Phone: 719-471-7064 | |
William A Munson, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 325 E Fontanero St, Colorado Springs Endocrine Clinic Pc, Colorado Springs, CO 80907 Phone: 719-636-3829 Fax: 719-636-1387 | |
Barbara E Johnston, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 175 S Union Blvd Ste 350, Colorado Springs, CO 80910 Phone: 719-633-5515 Fax: 719-365-1307 | |
Dr. Raymond L. Wahl, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2502 E Pikes Peak Ave, Colorado Springs, CO 80909 Phone: 719-630-6440 Fax: 719-228-6603 | |
Dr. Duane Ryan Spaulding, M.D., F.A.C.P. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6722 Northface Ln, Colorado Springs, CO 80919 Phone: 719-590-9338 | |
Dr. Wendy Marie Bamberg, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 301 S Union Blvd, Colorado Springs, CO 80910 Phone: 719-578-3199 |